The U.S. Food and Drug Administration will meet its targets for completing reviews of new drugs despite mass firings at the ...

Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...

The Food and Drug Administration is phasing out the use of petroleum-based synthetic dyes by the end of 2026 - a change that ...

Dr. Marty Makary has been outspoken about vaccine mandates and other public health measures, so how does the Food and Drug ...

Stealth BioTherapeutics had expected the FDA to respond on Tuesday to its marketing application for elamipretide to treat ...

Color is powerful driver of consumer behavior and changes can backfire, Giusti noted. In 2016, food giant General Mills ...

Merck will grow its U.S. manufacturing footprint with a $1 billion plant, making it the latest drugmaker to invest in the U.S ...

How the Trump administration’s health cuts could kill thousands of test animals - Hundreds of lab animals in West Virginia ...

A series of studies have raised concerns by associating synthetic food colorings with health risks from hyperactivity to ...

Recently, the FDA announced the removal of certain compounded GLP1 ingredients from its drug shortage list. These ingredients ...

Future of Healthcategory· April 18, 2025 Sanofi-Regeneron's Dupixent gets FDA's nod for skin condition The U.S. Food and Drug Administration approved the use of Sanofi and Regeneron's blockbuster ...

The lawsuit argues that Trump and DOGE are unconstitutionally reorganizing the federal government through mass firings of workers.